Nuance's voicebot helps people book COVID-19 vaccines

By Leila Hawkins
The AI-powered voice solution from Nuance Communications is helping people book COVID-19 vaccines over the phone...

Software firm Nuance communications has developed a conversational voicebot to that can guide users to answer questions about COVID-19, confirm their eligibility for a vaccination and schedule appointments where available. 

One of Nuance’s Intelligent Engagement solutions, it also sends the user an SMS text to confirm appointments after the call.

The voicebot is currently being deployed by Walgreens - one of the largest pharmacy retail chains in the US. Walgreens customers can call a helping or individual store to speak to the voicebot, which is available in English and Spanish, 24 hours a day. 

"Ensuring equitable access to care is essential," said Robert Weideman, Executive Vice President and General Manager, Nuance. "Using our proven voice- and AI-powered solutions to help as many Walgreens customers as possible experience a more modern, convenient, and secure process for scheduling their COVID vaccine appointments is one of the most important outcomes we can achieve."

Nuance are pioneers in conversational AI and have also developed Dragon Medical One, a cloud-based, GDPR-compliant speech recognition tool that enables clinicians to use their voice to capture patient information. This data can then be stored across a number of different platforms. 

In February this year the tool was given the #1 Best in KLAS Award for Speech Recognition (Front-end EMR). 

Share

Featured Articles

Oracle: Interoperable Healthcare Systems 'Vital'

World's largest database management company Oracle stresses importance of inoperable healthcare systems for improving patient outcomes

Workplace Health Provision Easing Burden on Public Health

A Q&A with David Joerring, Founder & CEO of HealthKey, which connects health insurers and employers with digital health providers through API integrations

Healthcare Business roundup: Baxter, Sanofi & Eli Lilly

Baxter International to sell kidney care spin-off Vantive; Sanofi's consumer health unit ‘to be separated’; Eli Lilly to buy Morphic Holding for $3.2bn

Trane Technologies Helping US Hospitals Meet Climate Pledge

Sustainability

Nestlé Health Science Targets Weight Loss Side-Effects

Medical Devices & Pharma

Eli Lilly Alzheimer's Drug Kisunla Approved in US by FDA

Medical Devices & Pharma